Strikingly, the luminescence signal and tumor weight were significantly decreased in mice treated with gemcitabine and the Akt inhibitor and indicated slightly changes treated with Akt inhibitor alone and AsPC-1/vector cells (Fig. 5c and Supplementary Fig. S3b, c). The gene discussed is AKT1; the disease is neoplasm.